Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
Your comments are welcome:
submit feedback
|
|
Disclosure reporting details |
Back to search detail summary
|
:
01/01/2021 - 06/30/2021
|
Authorizing Officer name
|
John
F.X.
Heffernan
|
Title
|
Principal
|
Business name
|
Park Street Strategies, LLC
|
Address
|
121 Mount Vernon Street
|
City, state, zip code
|
Boston, MA 02108
|
Country
|
US
|
Phone
|
617-981-0015
|
|
|
Client Compensation
|
Massachusetts Biotechnology Council |
$60,000.00
|
Biotechnology Innovation Organization (BIO) |
$27,000.00
|
Sage Therapeutics |
$33,000.00
|
UCB, Inc. |
$22,500.00
|
Horizon Therapeutics USA, Inc. |
$36,000.00
|
PTC Therapeutics |
$25,000.00
|
Bastion Elevate |
$12,000.00
|
Total salaries received |
$215,500.00
|
|
|
|
Compensation/Salaries Paid
|
John F.X. Heffernan
|
$65,000.00
|
Total salaries paid |
$65,000.00
|
|
|
Activities, Bill Numbers and Titles
|
No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
|
Operating Expenses
|
06/30/2021 |
Staples
|
Photocopies, scans
|
$15.98
|
06/23/2021 |
Apple
|
Computer equipment, supplies
|
$1,124.13
|
06/30/2021 |
Staples
|
Computer equipment, supplies
|
$52.05
|
02/05/2021 |
Amazon
|
Computer equipment, supplies
|
$25.47
|
03/19/2021 |
New England Council
|
Professional dues
|
$1,000.00
|
02/15/2021 |
Greater Boston Chamber of Commerce
|
Professional dues
|
$1,350.00
|
06/30/2021 |
Meeting House Office & Retail
|
Internet fees
|
$100.00
|
06/30/2021 |
Riley & Dever, P.C.
|
Legal fees
|
$1,450.00
|
06/30/2021 |
Amazon
|
Office supplies, equipment
|
$74.35
|
06/30/2021 |
Meeting House Office & Retail
|
Rent
|
$3,000.00
|
06/30/2021 |
AT&T Wireless
|
Telephone, cell phone, handheld
|
$630.66
|
| | Total operating expenses |
$8,822.64
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|
|
Lobbyist: John F.X. Heffernan
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
627
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
736
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
2058
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1224
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
650
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1272
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
House Bill
|
201
|
An Act advancing health care research and decision-making centered on patients and people with
disabilities
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
753
|
An Act advancing health care research and decision-making centered on patients and people with disabilities
|
Support
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1278
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1256
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F.X. Heffernan
|
Client:
Sage Therapeutics
|
|
Senate Bill
|
738
|
An Act protecting pregnant and postpartum patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1518
|
An Act advancing the health of pregnant persons
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F.X. Heffernan
|
Client:
Horizon Therapeutics USA, Inc.
|
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
2058
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Support
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F.X. Heffernan
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F.X. Heffernan
|
Senate Bill
|
2058
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F.X. Heffernan
|
Client:
Massachusetts Biotechnology Council
|
|
House Bill
|
1190
|
An Act relating to patient cost, benefit, and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2096
|
An Act relative to the establishment of and payments into an opioid stewardship fund
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
613
|
An Act protecting research animals
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID-Order No. 21, 30, and 32 which extended the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2235
|
An Act to improve patient access to prescription medication
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
627
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
786
|
An Act to bring down the cost of prescription drugs
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID-Order No. 33, which authorized the re-opening of certain brick-and-mortar premises designated as Phase I workplace
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
743
|
An Act establishing a commission to study a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1272
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3827
|
An Act relative to transferring federal funds to the federal COVID-19 response fund
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
89
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1202
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2397
|
An Act creating an obesity task force and pilot program
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1209
|
An Act relative to banning noncompetition agreements in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 , All Provider Bulletin 291
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1069
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
House Bill
|
1303
|
An Act relative to compensation for victims of opioids
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
753
|
An Act advancing health care research and decision-making centered on patients and people with disabilities
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2058
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
55
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and relief to employers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1198
|
An Act to ensure access to the full range of treatment options for people with obesity
|
Support
|
$0.00
|
N/A
|
House Bill
|
2325
|
An Act relative to pharmacy testing
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
639
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID-Order No. 35, clarifying the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
3787
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
684
|
An Act to reduce the cost of pharmacy benefits
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
House Bill
|
1278
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1533
|
An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
60
|
to a study of the rules of the House
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
642
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19, All Provider Bulletin 289
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1107
|
An Act relative to health insurer reserve requirements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1307
|
An Act establishing a study to examine the feasibility of state manufactured generic prescription drugs
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
35
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1059
|
An Act relative to patient financial protection
|
Support
|
$0.00
|
N/A
|
House Bill
|
1279
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
736
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
90
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1210
|
An Act relative to drug prices paid by carriers
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
2403
|
An Act to establish a sharps stewardship program
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
647
|
An Act relative to health insurer reserve requirements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1250
|
An Act relative to clarifying legislative intent regarding the non-competition law
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth (Executive Office of Health and Human Services) COVID19 Emergency Waivers - bulletins 21, 22 removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-coverage-and-payment-policies
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
357
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
House Bill
|
3771
|
An Act providing for Massachusetts COVID-19 emergency paid sick leave
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
664
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring Executive Office of Health and Human Services, Orderly Transition of Public Health Emergency Orders Issued Pursuant to Governor Baker’s State of Emergency Declared March 10, 2020
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1123
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
38
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
770
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring March 10, Governor Baker’s – State of Emergency to respond to Covid-19 Order
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1155
|
An Act to ensure access to generic medications
|
Support
|
$0.00
|
N/A
|
House Bill
|
1822
|
An Act prohibiting body size discrimination
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
215
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID- Order No. 13, which designated certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
201
|
An Act advancing health care research and decision-making centered on patients and people with disabilities
|
Support
|
$0.00
|
N/A
|
House Bill
|
1224
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
3702
|
An Act providing for Massachusetts COVID-19 emergency paid sick leave
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
650
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1294
|
An Act strengthening prescription drug safety and drug stewardship
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring Governor Baker’s Steps for COVID-19 Vaccine Distribution
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F.X. Heffernan
|
Client:
Biotechnology Innovation Organization (BIO)
|
|
House Bill
|
743
|
An Act establishing a commission to study a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1272
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3827
|
An Act relative to transferring federal funds to the federal COVID-19 response fund
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
696
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1481
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
House Bill
|
1278
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
728
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1533
|
An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
55
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and relief to employers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1198
|
An Act to ensure access to the full range of treatment options for people with obesity
|
Support
|
$0.00
|
N/A
|
House Bill
|
2325
|
An Act relative to pharmacy testing
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
639
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID-Order No. 35, clarifying the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1107
|
An Act relative to health insurer reserve requirements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1307
|
An Act establishing a study to examine the feasibility of state manufactured generic prescription drugs
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
35
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2485
|
Senate FY 2022 Budget
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
90
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1210
|
An Act relative to drug prices paid by carriers
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
2403
|
An Act to establish a sharps stewardship program
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
647
|
An Act relative to health insurer reserve requirements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1250
|
An Act relative to clarifying legislative intent regarding the non-competition law
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 , All Provider Bulletin 291
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1059
|
An Act relative to patient financial protection
|
Support
|
$0.00
|
N/A
|
House Bill
|
1279
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
736
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1191
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2235
|
An Act to improve patient access to prescription medication
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
627
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
786
|
An Act to bring down the cost of prescription drugs
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID-Order No. 33, which authorized the re-opening of certain brick-and-mortar premises designated as Phase I workplace
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
60
|
to a study of the rules of the House
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1201
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2377
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
642
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19, All Provider Bulletin 289
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1069
|
An Act empowering health care consumers
|
Support
|
$0.00
|
N/A
|
House Bill
|
1303
|
An Act relative to compensation for victims of opioids
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
753
|
An Act advancing health care research and decision-making centered on patients and people with disabilities
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2058
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
201
|
An Act advancing health care research and decision-making centered on patients and people with disabilities
|
Support
|
$0.00
|
N/A
|
House Bill
|
1224
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
3702
|
An Act providing for Massachusetts COVID-19 emergency paid sick leave
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
650
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1294
|
An Act strengthening prescription drug safety and drug stewardship
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth (Executive Office of Health and Human Services) COVID19 Emergency Waivers - bulletins 21, 22 removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-coverage-and-payment-policies
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
89
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1202
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2397
|
An Act creating an obesity task force and pilot program
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1209
|
An Act relative to banning noncompetition agreements in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19, All Provider Bulletin 289
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1123
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
38
|
An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
770
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring March 10, Governor Baker’s – State of Emergency to respond to Covid-19 Order
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1190
|
An Act relating to patient cost, benefit, and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
2096
|
An Act relative to the establishment of and payments into an opioid stewardship fund
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
613
|
An Act protecting research animals
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
785
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID-Order No. 21, 30, and 32 which extended the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
357
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1237
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
House Bill
|
3771
|
An Act providing for Massachusetts COVID-19 emergency paid sick leave
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
664
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1465
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring Governor Baker’s Steps for COVID-19 Vaccine Distribution
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
3787
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
684
|
An Act to reduce the cost of pharmacy benefits
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1480
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring Executive Office of Health and Human Services, Orderly Transition of Public Health Emergency Orders Issued Pursuant to Governor Baker’s State of Emergency Declared March 10, 2020
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1155
|
An Act to ensure access to generic medications
|
Support
|
$0.00
|
N/A
|
House Bill
|
1822
|
An Act prohibiting body size discrimination
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
215
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Office of the Governor
|
Monitoring Governor Baker’s COVID- Order No. 13, which designated certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
01/06/2021 | John F.X. Heffernan |
Juan Pablo Jaramillo
|
State Representative
|
$200.00
|
02/10/2021 | John F.X. Heffernan |
Aaron Michlewitz
|
State Representative
|
$200.00
|
02/16/2021 | John F.X. Heffernan |
Jon Santiago
|
State Representative
|
$200.00
|
02/22/2021 | John F.X. Heffernan |
Michael J. Rodrigues
|
State Senate
|
$200.00
|
02/24/2021 | John F.X. Heffernan |
Nick Collins
|
State Senate
|
$200.00
|
03/09/2021 | John F.X. Heffernan |
Adrian Madaro
|
State Representative
|
$200.00
|
03/10/2021 | John F.X. Heffernan |
Paul Donato
|
State Representative
|
$200.00
|
03/11/2021 | John F.X. Heffernan |
Marjorie Decker
|
State Representative
|
$200.00
|
03/11/2021 | John F.X. Heffernan |
Mike Rush
|
State Senate
|
$200.00
|
03/29/2021 | John F.X. Heffernan |
Karen Spilka
|
State Senate
|
$200.00
|
04/09/2021 | John F.X. Heffernan |
Joe Boncore
|
State Senate
|
$200.00
|
04/11/2021 | John F.X. Heffernan |
David Biele
|
State Representative
|
$200.00
|
04/13/2021 | John F.X. Heffernan |
Bill Driscoll Jr.
|
State Representative
|
$200.00
|
04/14/2021 | John F.X. Heffernan |
Dave Rogers
|
State Representative
|
$200.00
|
04/26/2021 | John F.X. Heffernan |
Adam Hinds
|
State Senate
|
$200.00
|
05/04/2021 | John F.X. Heffernan |
John Lawn
|
State Representative
|
$200.00
|
05/17/2021 | John F.X. Heffernan |
Brendan Crighton
|
State Senate
|
$200.00
|
05/20/2021 | John F.X. Heffernan |
Ed Coppinger
|
State Representative
|
$200.00
|
06/14/2021 | John F.X. Heffernan |
Jerry Parisella
|
State Representative
|
$200.00
|
06/14/2021 | John F.X. Heffernan |
Sal DiDomenico
|
State Senate
|
$200.00
|
| | | Total contributions |
$4,000.00
|
|
|
|
|
|